Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptive Biotechnologies Corp

10.09
+0.22002.23%
Post-market: 10.090.00000.00%18:34 EDT
Volume:1.06M
Turnover:10.81M
Market Cap:1.53B
PE:-10.53
High:10.37
Open:10.04
Low:9.92
Close:9.87
Loading ...

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

GlobeNewswire
·
06 Feb

The 5.4% return this week takes Adaptive Biotechnologies' (NASDAQ:ADPT) shareholders one-year gains to 99%

Simply Wall St.
·
29 Jan

Adaptive Biotechnologies Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
28 Jan

Why Adaptive Biotechnologies Corporation (ADPT) Is Skyrocketing Now

Insider Monkey
·
24 Jan

Why Is Andreas Halvorsen Bullish On Adaptive Biotechnologies Corporation (ADPT) Now?

Insider Monkey
·
23 Jan

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

GlobeNewswire
·
23 Jan

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

Zacks
·
17 Jan

Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?

Zacks
·
16 Jan

Adaptive Biotechnologies, NeoGenomics to Support Minimal Residual Disease Monitoring Options for Blood Cancer Patients

MT Newswires Live
·
14 Jan

Adaptive, NeoGenomics partner to expand access to disease monitoring

TIPRANKS
·
14 Jan

BRIEF-Adaptive Biotechnologies Corp And Neogenomics Announce Strategic Collaboration

Reuters
·
14 Jan

Adaptive Biotechnologies Corp: Specific Financial Terms of Agreement Are Not Disclosed

THOMSON REUTERS
·
14 Jan

Adaptive Biotechnologies and Neogenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

THOMSON REUTERS
·
14 Jan

Adaptive Biotechnologies Corp: Co and Neogenomics Announce Strategic Collaboration

THOMSON REUTERS
·
14 Jan

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for Clonoseq® Test for Minimal Residual Disease Assessment Is Effective as of January 1St, 2025

THOMSON REUTERS
·
07 Jan

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Teladoc (TDOC)

TIPRANKS
·
03 Jan

Cathie Wood Takes Profit On Hot AI Stock Palantir Again, Continues To Sell Block Shares Amid Bitcoin Buzz

Benzinga
·
27 Dec 2024

Adaptive Biotechnologies Is Maintained at Buy by BTIG

Dow Jones
·
19 Dec 2024

Adaptive Biotechnologies Corp : Btig Raises Target Price to $9 From $8

THOMSON REUTERS
·
18 Dec 2024

Adaptive Biotechnologies price target raised to $9 from $8 at BTIG

TIPRANKS
·
18 Dec 2024